Vaxcyte Insider Trades
NASDAQ: PCVXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 71.38 0.00%
Last 12 months
- Purchases
- 0 · $0
- Sales
- 2 · $3.21M
- Shares bought / sold
- 0 / 37.00K
- Net activity
- Net selling $3.2 million
Vaxcyte insider activity
Over the last 12 months, Vaxcyte insiders reported 4 transactions on SEC Form 4: 0 open-market purchases and 2 sales. Insiders bought $0 and sold $3.2 million worth of stock, for net insider selling of $3.2 million. The largest seller was Cowan Elvia, with $1.6 million in reported sales.
The most recent filing shows Wassil Jim (EVP, Chief Scientific Ofc, COO) reporting a transaction in 18,000 shares at $5.35 on Oct 5, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PCVX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PCVX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 5, 2026 | Cowan ElviaSVP, Finance & CAO | Sale | 19,000 | $1.65M | Form 4 |
| Oct 5, 2026 | Cowan ElviaSVP, Finance & CAO | Option exercise | 19,000 | $492.48K | Form 4 |
| Oct 5, 2026 | Wassil JimEVP, Chief Scientific Ofc, COO | Sale | 18,000 | $1.56M | Form 4 |
| Oct 5, 2026 | Wassil JimEVP, Chief Scientific Ofc, COO | Option exercise | 18,000 | $96.30K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4